Gastroenterology

A Wealth of Experience

We have collaborated with our clients on projects to research gastrointestinal (GI) disease, GI treatment, and complications and comorbidities of GI disease.  Our experience includes:

  • Celiac disease
  • Chronic idiopathic constipation
  • Crohn’s disease
  • Diverticulitis
  • Dyspepsia
  • Gastroesophageal reflux disease (GERD)
  • Pediatric GERD
  • Gastroparesis
  • Gastric cancer
  • Irritable bowel syndrome (IBS) (diarrhea-predominant & constipation-predominant)
  • Opioid-induced constipation
  • Postoperative ileus
  • Ulcerative colitis

Types of Projects

We have implemented studies to help our clients develop strategies in the gastrointestinal (GI) market and to develop and gain market access for products to treat GI diseases and complications arising from treatment of GI illnesses. Recent projects have included:

Our Experts

Sheri Fehnel
Vice President, Patient-Centered Outcomes Assessment
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Beth Sherrill
Vice President, Biostatistics
Elena Rivero
Director, Epidemiology
Shahnaz Khan
Executive Director, Market Access and Outcomes Strategy
Sean Candrilli
Vice President, Health Economics
Claire Ervin
Senior Director, Patient-Centered Outcomes Assessment
Allen Mangel
Executive Vice President, RTI Health Solutions
James Twiss
Senior Research Scientist, Patient-Centered Outcomes Assessment
Valerie Williams
Senior Director, Psychometrics, Patient-Centered Outcomes Assessment
Jin Yang
Senior Associate, Market Access and Outcomes Strategy
Keith Davis
Head, Health Economics
David McSorley
Director, Biostatistics, US
Caroline Ling
Senior Director and HTA Specialist Market Access and Outcomes Strategy
Lauren Nelson
Senior Director, Psychometrics, Patient-Centered Outcomes Assessment
Carol Mansfield
Senior Economist and Head, Health Preference Assessment
Brett Hauber
Senior Economist and VP, Health Preference Assessment
Bintu Sherif
Director, Biostatistics
Katherine Stull
Director, Health Economics
Annete Njue
Director, Market Access and Outcomes Strategy
Rebecca Crawford
Senior Research Scientist, Patient-Centered Outcomes Assessment
Stephanie Earnshaw
Vice President, Health Economics
Ann Colosia
Associate Director, Market Access and Outcomes Strategy
Kelly Hollis
Vice President, Surveys and Observational Studies
Dawn Odom
Vice President, Head, Biostatistics
Lynne Hamm
Vice President, Clinical and Medical Services

Selected Recent Gastroenterology Publications

Fortuny J, Gilsenan AW, Cainzos-Achirica M, Cantero OF, Flynn RW, Garcia-Rodriguez L, Kollhorst B, Karlsson P, Linner L, MacDonald TM, Plana E, Ruigomez A, Schink T, Ziemiecki R, Andrews EB. Cohort study of the relative incidence of major cardiovascular events among patients initiating prucalopride versus a matched comparator cohort in a multinational study: study design and comparability of cohorts. Poster presented at the 35th Annual ICPE Conference; August 27, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):627.